HER2-Targeted Therapies in HER2-Low-Expressing Breast Cancer
J Clin Oncol
.
2020 Oct 1;38(28):3350-3351.
doi: 10.1200/JCO.20.00657.
Epub 2020 Jul 13.
Author
Tim Johannes Adrianus Dekker
1
Affiliation
1
Tim Johannes Adrianus Dekker, PhD, Department of Internal Medicine, Haaglanden Medisch Centrum, The Hague.
PMID:
32658628
DOI:
10.1200/JCO.20.00657
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms* / drug therapy
Breast Neoplasms* / genetics
Camptothecin / analogs & derivatives
Humans
Immunoconjugates*
Trastuzumab
Substances
Immunoconjugates
trastuzumab deruxtecan
Trastuzumab
Camptothecin